|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. Feb 4–2021.(Epub ahead
of print). doi: 10.3322/caac.21660. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brown SB and Hankinson SE: Endogenous
estrogens and the risk of breast, endometrial, and ovarian cancers.
Steroids. 99:8–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fernández MF, Reina-Pérez I, Astorga JM,
Rodríguez-Carrillo A, Plaza-Díaz J and Fontana L: Breast cancer and
its relationship with the microbiota. Int J Environ Res Public
Health. 15:17472018. View Article : Google Scholar
|
|
5
|
Momenimovahed Z and Salehiniya H:
Epidemiological characteristics of and risk factors for breast
cancer in the world. Breast Cancer (Dove Med Press). 11:151–164.
2019.PubMed/NCBI
|
|
6
|
da Costa Vieira RA, Biller G, Uermura G,
Ruiz CA and Curado MP: Breast cancer screening in developing
countries. Clinics (Sao Paulo). 72:244–253. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Howlader N, Cronin KA, Kurian AW and
Andridge R: Differences in breast cancer survival by molecular
subtypes in the United States. Cancer Epidemiol Biomarkers Prev.
27:619–626. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Turnbaugh PJ, Ley RE, Hamady M,
Fraser-Liggett CM, Knight R and Gordon JI: The human microbiome
project. Nature. 449:804–810. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Parida S and Sharma D: Microbial
alterations and risk factors of breast cancer: Connections and
mechanistic insights. Cells. 9:10912020. View Article : Google Scholar
|
|
10
|
Urbaniak C, Cummins J, Brackstone M,
Macklaim JM, Gloor GB, Baban CK, Scott L, O'Hanlon DM, Burton JP,
Francis KP, et al: Microbiota of human breast tissue. Appl Environ
Microbiol. 80:3007–3014. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Toumazi D and Constantinou C: A fragile
balance: The important role of the intestinal microbiota in the
prevention and management of colorectal cancer. Oncology.
98:593–602. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chung YR, Kim HJ, Kim YA, Chang MS, Hwang
KT and Park SY: Diversity index as a novel prognostic factor in
breast cancer. Oncotarget. 8:97114–97126. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xuan C, Shamonki JM, Chung A, Dinome ML,
Chung M, Sieling PA and Lee DJ: Microbial dysbiosis is associated
with human breast cancer. PLoS One. 9:e837442014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Urbaniak C, Gloor GB, Brackstone M, Scott
L, Tangney M and Reid G: The microbiota of breast tissue and its
association with breast cancer. Appl Environ Microbiol.
82:5039–5048. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chan AA, Bashir M, Rivas MN, Duvall K,
Sieling PA, Pieber TR, Vaishampayan PA, Love SM and Lee DJ:
Characterization of the microbiome of nipple aspirate fluid of
breast cancer survivors. Sci Rep. 6:280612016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Parida S and Sharma D: The power of small
changes: Comprehensive analyses of microbial dysbiosis in breast
cancer. Biochim Biophys Acta Rev Cancer. 1871:392–405. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hieken TJ, Chen J, Hoskin TL,
Walther-Antonio M, Johnson S, Ramaker S, Xiao J, Radisky DC,
Knutson KL, Kalari KR, et al: The microbiome of aseptically
collected human breast tissue in benign and malignant disease. Sci
Rep. 6:307512016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thompson KJ, Ingle JN, Tang X, Chia N,
Jeraldo PR, Walther-Antonio MR, Kandimalla KK, Johnson S, Yao JZ,
Harrington SC, et al: A comprehensive analysis of breast cancer
microbiota and host gene expression. PLoS One. 12:e01888732017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Flores R..Shi J, Fuhrman B, Xu X, Veenstra
TD, Gail MH, Gajer P, Ravel J and Goedert JJ: Fecal microbial
determinants of fecal and systemic estrogens and estrogen
metabolites: A cross-sectional study. J Transl Med. 10:2532012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang H, Altemus J, Niazi F, Green H,
Calhoun BC, Sturgis C, Grobmyer SR and Eng C: Breast tissue, oral
and urinary microbiomes in breast cancer. Oncotarget.
8:88122–88138. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Banerjee S, Tian T, Wei Z, Shih N, Feldman
MD, Peck KN, DeMichele AM, Alwine JC and Robertson ES: Distinct
microbial signatures associated with different breast cancer types.
Front Microbiol. 9:9512018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Parida S and Sharma D: The
microbiome-estrogen connection and breast cancer risk. Cells.
8:16422019. View Article : Google Scholar
|
|
23
|
Minelli EB, Beghini AM, Vesentini S,
Marchiori L, Nardo G, Cerutti R and Mortani E: Intestinal
microflora as an alternative metabolic source of estrogens in women
with uterine leiomyoma and breast cancer. Ann N Y Acad Sci.
595:473–479. 1990. View Article : Google Scholar
|
|
24
|
Zhu J, Liao M, Yao Z, Liang W, Li Q, Liu
J, Yang H, Ji Y, Wei W, Tan A, et al: Breast cancer in
postmenopausal women is associated with an altered gut metagenome.
Microbiome. 6:1362018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Inan MS, Rasoulpour RJ, Yin L, Hubbard AK,
Rosenberg DW and Giardina C: The luminal short-chain fatty acid
butyrate modulates NF-kappaB activity in a human colonic epithelial
cell line. Gastroenterology. 118:724–734. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Heinken A and Thiele I: Systematic
prediction of health-relevant human-microbial co-metabolism through
a computational framework. Gut Microbes. 6:120–130. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Eslami-S Z, Majidzadeh-A K, Halvaei S,
Babapirali F and Esmaeili R: Microbiome and breast cancer: New role
for an ancient population. Front Oncol. 10:1202020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Z, Tang H, Chen P, Xie H and Tao Y:
Demystifying the manipulation of host immunity, metabolism, and
extraintestinal tumors by the gut microbiome. Signal Transduct
Target Ther. 4:412019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mani S: Microbiota and breast cancer. Prog
Mol Biol Transl Sci. 151:217–229. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Komorowski AS and Pezo RC: Untapped
‘-omics’: The microbial metagenome, estrobolome, and their
influence on the development of breast cancer and response to
treatment. Breast Cancer Res Treat. 179:287–300. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Flores R, Shi J, Gail MH, Gajer P, Ravel J
and Goedert JJ: Association of fecal microbial diversity and
taxonomy with selected enzymatic functions. PLoS One. 7:e397452012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fuhrman BJ, Feigelson HS, Flores R, Gail
MH, Xu X, Ravel J and Goedert JJ: Associations of the fecal
microbiome with urinary estrogens and estrogen metabolites in
postmenopausal women. J Clin Endocrinol Metab. 99:4632–4640. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Buchta Rosean C, Bostic RR, Ferey JCM,
Feng TY, Azar FN, Tung KS, Dozmorov MG, Sirmnova E, Bos PD and
Rutlowski MR: Preexisting commensal dysbiosis is a host-intrinsic
regulator of tissue inflammation and tumour cell dissemination in
hormone receptor-positive breast cancer. Cancer Res. 79:3662–3675.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Malik SS, Saeed A, Baig M, Asif N, Masood
N and Yasmin A: Anticarcinogenecity of microbiota and probiotics in
breast cancer. Int J Food Prop. 21:655–666. 2018. View Article : Google Scholar
|
|
35
|
Yang J, Tan Q, Fu Q, Zhou Y, Hu Y, Tang S,
Zhou Y, Zhang J, Qiu J and Lv Q: Gastrointestinal microbiome and
breast cancer: Correlations, mechanisms and potential clinical
implications. Breast Cancer. 24:220–228. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Imani Fooladi AA, Yazdi MH, Pourmand MR,
Mirshafiey A, Hassan ZM, Azizi T, Mahdavi M and Soltan Dallal MM:
Th1 cytokine production induced by Lactobacillus acidophilus
in BALB/c Mice bearing transplanted breast tumor. Jundishapur J
Microbiol. 8:e173542015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hassan Z, Mustafa S, Rahim RA and Isa NM:
Anti-breast cancer effects of live, heat-killed and cytoplasmic
fractions of Enterococcus faecalis and Staphylococcus
hominis isolated from human breast milk. In Vitro Cell Dev Biol
Anim. 52:337–348. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Esfandiary A, Taherian-Esfahani Z,
Abedin-Do A, Mirfakhraie R, Shirzad M, Ghafouri-Fard S and
Motevaseli E: Lactobacilli modulate hypoxia-inducible factor
(HIF)-1 regulatory pathway in triple negative breast cancer cell
line. Cell J. 18:237–244. 2016.PubMed/NCBI
|
|
39
|
Bharti V, Singh S, Ahirwal L, Mehta A and
Jain N: Cytotoxicity of live whole cell, heat killed cell and cell
free extract of lactobacillus strain in u-87 human glioblastoma
cell line and mcf-7 breast cancer cell line. Int J Probiotics
Prebiotics. 10:153–158. 2015.
|
|
40
|
Kadirareddy RH, Vemuri SG and Palempalli
UM: Probiotic conjugated linoleic acid mediated apoptosis in breast
cancer cells by downregulation of NFκB. Asian Pac J Cancer Prev.
17:3395–3403. 2016.PubMed/NCBI
|
|
41
|
De Moreno de LeBlanc A, Matar C, Thériault
C and Perdigón G: Effects of milk fermented by Lactobacillus
helveticus R389 on immune cells associated to mammary glands in
normal and a breast cancer model. Immunobiology. 210:349–358. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lakritz JR, Poutahidis T, Levkovich T,
Varian BJ, Ibrahim YM, Chatzigiagkos A, Mirabal S, Alm EJ and
Erdman SE: Beneficial bacteria stimulate host immune cells to
counteract dietary and genetic predisposition to mammary cancer in
mice. Int J Cancer. 135:529–540. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Van't Veer P, Dekker JM, Lamers JW, Kok
FJ, Schouten EG, Brants HA, Sturmans F and Hermus RJ: Consumption
of fermented milk products and breast cancer: A case-control study
in The Netherlands. Cancer Res. 49:4020–4023. 1989.PubMed/NCBI
|
|
44
|
Chagas CE, Rogero MM and Martini LA:
Evaluating the links between intake of milk/dairy products and
cancer. Nutr Rev. 70:294–300. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Soltan Dallal MM, Yazdi MH, Holakuyee M,
Hassan ZM, Abolhassani M and Mahdavi M: Lactobacillus casei
ssp.casei induced Th1 cytokine profile and natural killer cells
activity in invasive ductal carcinoma bearing mice. Iran J Allergy
Asthma Immunol. 11:183–189. 2012.PubMed/NCBI
|
|
46
|
Yazdi MH, Mahdavi M, Setayesh N, Esfandyar
M and Shahverdi AR: Selenium nanoparticle-enriched Lactobacillus
brevis causes more efficient immune responses in vivo and
reduces the liver metastasis in metastatic form of mouse breast
cancer. DARU. 21:332013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zamberi NR, Abu N, Mohamed NE, Nordin N,
Keong YS, Beh BK, Zakaria ZA, Nik Abdul Rahman NM and Alitheen NB:
The antimetastatic and antiangiogenesis effects of kefir water on
murine breast cancer cells. Integr Cancer Ther. 15:NP53–NP66. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Suez J, Zmora N, Segal E and Elinav E: The
pros, cons and many knowns of probiotics. Nat Med. 25:716–729.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Bafeta A, Koh M, Riveros C and Ravaud P:
Harms reporting in randomized controlled trials of interventions
aimed at modifying microbiota: A systematic review. Ann Intern Med.
169:240–247. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Mayo Clinic, . Engineering Gut Microbiome
to Target Breast Cancer. https://clinicaltrials.gov/ct2/show/NCT03358511NLM
identifier: NCT03358511. October 28–2020
|
|
51
|
Universidad de Granada, . Breast and
Cancer Its Relationship With the Microbiota (MICROMA). https://clinicaltrials.gov/ct2/show/NCT03885648NLM
identifier: NCT03885648. October 28–2020
|
|
52
|
Hackensack Meridian Health, . Gut and
Intratumoral Microbiome Effect on the Neoadjuvant
Chemotherapy-induced Immunosurveillance in Triple Negative Breast
Cancer. https://clinicaltrials.gov/ct2/show/NCT03586297NLM
identifier: NCT03586297. October 28–2020
|
|
53
|
First Affiliated Hospital of Harbin
Medical University, . Intestinal Microbiota of Breast Cancer
Patients Undergoing Chemotherapy. https://clinicaltrials.gov/ct2/show/NCT04138979NLM
identifier: ID: NCT04138979. October 28–2020
|
|
54
|
Lawson Health Research Institute, .
Probiotics and Breast Health. https://clinicaltrials.gov/ct2/show/NCT03290651NLM
identifier: NCT03290651. October 28–2020
|
|
55
|
Mayo Clinic, . A Pilot Trial of
Preoperative Oral Microbiota-based Investigational New Drug
(RBX7455). https://clinicaltrials.gov/ct2/show/NCT04139993NLM
identifier: NCT04139993. October 28–2020
|
